{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:37:20Z","timestamp":1777016240058,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006190","name":"Politechnika Gda\u0144ska","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118786","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:52:19Z","timestamp":1763747539000},"page":"118786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Apoptosis-promoting autophagy mediates anti-migratory effects of unsymmetrical bisacridines in pancreatic cancer cells"],"prefix":"10.1016","volume":"193","author":[{"given":"Agnieszka","family":"Kurdyn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1589-9350","authenticated-orcid":false,"given":"Bo\u017cena","family":"Peza\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Paluszkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118786_bib1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/diagnostics11030562","article-title":"Pancreatic ductal adenocarcinoma: epidemiology and risk factors","volume":"11","author":"Ushio","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.biopha.2025.118786_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5334\/aogh.4019","article-title":"Global, regional, and national burden of pancreatic cancer, 1990-2019: results from the global burden of disease study 2019","volume":"89","author":"Kan","year":"2023","journal-title":"Ann. Glob. Heal"},{"key":"10.1016\/j.biopha.2025.118786_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50756","article-title":"NALIRIFOX, FOLFIRINOX, and gemcitabine with nab-paclitaxel as first-line chemotherapy for metastatic pancreatic cancer","volume":"7","author":"Nichetti","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.biopha.2025.118786_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112599","article-title":"Design, synthesis and high antitumor potential of new unsymmetrical bisacridine derivatives towards human solid tumors, specifically pancreatic cancers and their unique ability to stabilize DNA G-quadruplexes","volume":"204","author":"Paluszkiewicz","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118786_bib5","series-title":"Asymmetric Bis-acridines with Antitumour Activity and Their Uses","author":"Konopa","year":"2023"},{"key":"10.1016\/j.biopha.2025.118786_bib6","series-title":"Asymmetric Bis-Acridines with Antitumor Activity and Use Thereof","author":"Konopa","year":"2019"},{"key":"10.1016\/j.biopha.2025.118786_bib7","series-title":"Asymmetric Bis-Acridines with Antitumor Activity and Use Thereof","author":"Konopa","year":"2017"},{"key":"10.1016\/j.biopha.2025.118786_bib8","series-title":"Asymmetric Bis-Acridines with Antitumour Activity and Their Uses","author":"Konopa","year":"2023"},{"key":"10.1016\/j.biopha.2025.118786_bib9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1734-1140(11)70499-6","article-title":"Natural and synthetic acridines\/acridones as antitumor agents: their biological activities and methods of synthesis","volume":"63","author":"Cholewi\u0144ski","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2025.118786_bib10","unstructured":"WHO Chronicle. Geneva: World Health Organization 1976;30 (3):11."},{"key":"10.1016\/j.biopha.2025.118786_bib11","first-page":"266","article-title":"Clinical observations of the Ledakrin effects in treatment of patients with malignant neoplasms","volume":"8","author":"Piotrowska-Sowi\u0144ska","year":"1976","journal-title":"Mater. Med. Pol."},{"key":"10.1016\/j.biopha.2025.118786_bib12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ejca.2009.12.005","article-title":"Evaluation of the safety of C-1311 (SYMADEX) administered in a phase 1 dose escalation trial as a weekly infusion for 3 consecutive weeks in patients with advanced solid tumours","volume":"46","author":"Isambert","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2025.118786_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102513","article-title":"The interactions of Pu22 G-quadruplex, derived from c-MYC promoter sequence, with antitumor acridine derivatives\u2014an NMR\/MD combined study","volume":"36","author":"Laskowski","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biopha.2025.118786_bib14","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.3390\/ijms23063061","article-title":"c-Myc protein level affected by unsymmetrical bisacridines influences apoptosis and senescence induced in HCT116 colorectal and H460 lung cancer cells","volume":"23","author":"Paw\u0142owska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118786_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/ph14040317","article-title":"Metabolic profiles of new unsymmetrical bisacridine antitumor agents in electrochemical and enzymatic noncellular systems and in tumor cells","volume":"14","author":"Mieszkowska","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2025.118786_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s43440-024-00658-6","article-title":"c-Myc inhibition and p21 modulation contribute to unsymmetrical bisacridines-induced apoptosis and senescence in pancreatic cancer cells","volume":"77","author":"Kurdyn","year":"2025","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2025.118786_bib17","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.3390\/ijms26157557","article-title":"Pro-apoptotic effects of unsymmetrical bisacridines in 3D pancreatic multicellular tumor spheroids","volume":"26","author":"Kurdyn","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118786_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/102735","article-title":"Role of the crosstalk between autophagy and apoptosis in cancer","volume":"2013","author":"Su","year":"2013","journal-title":"J. Oncol."},{"key":"10.1016\/j.biopha.2025.118786_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/aps.2012.184","article-title":"Why should autophagic flux be assessed?","volume":"34","author":"Zhang","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2025.118786_bib20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4161\/auto.4600","article-title":"How to interpret LC3 immunoblotting","volume":"3","author":"Mizushima","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2025.118786_bib21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/cdd.2010.191","article-title":"The Beclin 1 network regulates autophagy and apoptosis","volume":"18","author":"Kang","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2025.118786_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41416-020-01039-5","article-title":"Autophagy as a therapeutic target in pancreatic cancer","volume":"124","author":"Piffoux","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2025.118786_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1049436","article-title":"Targeting autophagy in pancreatic cancer: the cancer stem cell perspective","volume":"12","author":"Troumpoukis","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2025.118786_bib24","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.3390\/cancers14143528","article-title":"Autophagy: a key player in pancreatic cancer progression and a potential drug target","volume":"14","author":"Gillson","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118786_bib25","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41419-023-06032-3","article-title":"The role of epithelial-mesenchymal transition and autophagy in pancreatic ductal adenocarcinoma invasion","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118786_bib26","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3390\/cancers15072169","article-title":"The cell biology of metastatic invasion in pancreatic cancer: updates and mechanistic insights","volume":"15","author":"Joshi","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118786_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pan.2015.02.011","article-title":"The epithelial to mesenchymal transition in pancreatic cancer: a systematic review","volume":"15","author":"Beuran","year":"2015","journal-title":"Pancreatology"},{"key":"10.1016\/j.biopha.2025.118786_bib28","first-page":"36","article-title":"Epithelial-mesenchymal transition: a hallmark in pancreatic cancer stem cell migration, metastasis formation, and drug resistance","volume":"6","author":"Safa","year":"2020","journal-title":"J. Cancer Metastas. Treat."},{"key":"10.1016\/j.biopha.2025.118786_bib29","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.ejca.2014.01.011","article-title":"Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs","volume":"50","author":"Hashimoto","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2025.118786_bib30","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41591-019-0367-9","article-title":"Protective autophagy elicited by RAF\u2192MEK\u2192ERK inhibition suggests a treatment strategy for RAS-driven cancers","author":"Kinsey","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2025.118786_bib31","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.1073\/pnas.1812410116","article-title":"Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion","volume":"116","author":"Elliott","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.118786_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109433","article-title":"Fluorinated thiazolidinol drives autophagic cell death in pancreatic cancer cells via AMPK activation and perturbation of critical sentinels of oncogenic signaling","volume":"343","author":"Kumar","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biopha.2025.118786_bib33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12859-021-04344-9","article-title":"CellProfiler 4: improvements in speed, utility and usability","volume":"22","author":"Stirling","year":"2021","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.biopha.2025.118786_bib34","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/ars.2013.5371","article-title":"An overview of autophagy: morphology, mechanism, and regulation","volume":"20","author":"Parzych","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.biopha.2025.118786_bib35","first-page":"1641","article-title":"E\u2011cadherin is downregulated by microenvironmental changes in pancreatic cancer and induces EMT","volume":"40","author":"Wang","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2025.118786_bib36","doi-asserted-by":"crossref","unstructured":"C. Rosty, M. GogginsIdentification of differentially expressed proteins in pancreatic cancer using a global proteomic approach. Pancreat. Cancer, vol. 9, New Jersey: Humana Press; 2012, pp. 189\u2013198. https:\/\/doi.org\/10.1385\/1-59259-780-7:189.","DOI":"10.1385\/1-59259-780-7:189"},{"key":"10.1016\/j.biopha.2025.118786_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/JCI177142","article-title":"Off-target autophagy inhibition by SHP2 allosteric inhibitors contributes to their antitumor activity in RAS-driven cancers","volume":"134","author":"Miao","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2025.118786_bib38","first-page":"7849","article-title":"Expression of Beclin 1 and Bcl\u20112 in pancreatic neoplasms and its effect on pancreatic ductal adenocarcinoma prognosis","volume":"14","author":"Song","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2025.118786_bib39","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3390\/cancers15030953","article-title":"Perturbation of autophagy by a beclin 1-targeting stapled peptide induces mitochondria stress and inhibits proliferation of pancreatic cancer cells","volume":"15","author":"Li","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118786_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1412565","article-title":"Rhus coriaria induces autophagic and apoptotic cell death in pancreatic cancer cells","volume":"15","author":"El Mahi","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118786_bib41","first-page":"2626","article-title":"Beclin-1-independent autophagy mediates programmed cancer cell death through interplays with endoplasmic reticulum and\/or mitochondria in colbat chloride-induced hypoxia","volume":"5","author":"Sun","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118786_bib42","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.3390\/molecules26216741","article-title":"Chloroquine potentiates the anticancer effect of pterostilbene on pancreatic cancer by inhibiting autophagy and downregulating the RAGE\/STAT3 Pathway","volume":"26","author":"Chen","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118786_bib43","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/1878-0261.12179","article-title":"CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species","volume":"12","author":"Fu","year":"2018","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.biopha.2025.118786_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/srep26165","article-title":"Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis","volume":"6","author":"Ranjan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118786_bib45","first-page":"631","article-title":"Role of autophagy in apoptotic regulation by Akt in pancreatic cancer","volume":"34","author":"Muilenburg","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biopha.2025.118786_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193990","article-title":"Chloroquine augments TRAIL-induced apoptosis and induces G2\/M phase arrest in human pancreatic cancer cells","volume":"13","author":"Monma","year":"2018","journal-title":"PLOS One"},{"key":"10.1016\/j.biopha.2025.118786_bib47","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1002\/1878-0261.13269","article-title":"Autophagy at the intersection of aging, senescence, and cancer","volume":"16","author":"Cassidy","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.biopha.2025.118786_bib48","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.omto.2019.04.005","article-title":"Restoring E-cadherin expression by natural compounds for anticancer therapies in genital and urinary cancers","volume":"14","author":"Song","year":"2019","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.biopha.2025.118786_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.869069","article-title":"Impact of vimentin on regulation of cell signaling and matrix remodeling","volume":"10","author":"Ostrowska-Podhorodecka","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.118786_bib50","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41420-024-02185-y","article-title":"Non-canonical translation in cancer: significance and therapeutic potential of non-canonical ORFs, m6A-modification, and circular RNAs","volume":"10","author":"Deng","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biopha.2025.118786_bib51","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1080\/15548627.2019.1569912","article-title":"Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells","volume":"15","author":"Wang","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2025.118786_bib52","doi-asserted-by":"crossref","first-page":"39839","DOI":"10.18632\/oncotarget.5674","article-title":"Inhibition of autophagy promotes metastasis and glycolysis by inducing ROS in gastric cancer cells","volume":"6","author":"Qin","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118786_bib53","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/15384047.2021.2017223","article-title":"Target c-Myc to treat pancreatic cancer","volume":"23","author":"Ala","year":"2022","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.biopha.2025.118786_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/2626545","article-title":"EI24 Suppresses tumorigenesis in pancreatic cancer via regulating c-Myc","volume":"2018","author":"Zang","year":"2018","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.biopha.2025.118786_bib55","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3389\/fphar.2020.00495","article-title":"Silencing c-Myc enhances the antitumor activity of bufalin by suppressing the HIF-1\u03b1\/SDF-1\/CXCR4 Pathway in Pancreatic Cancer Cells","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118786_bib56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.52783\/jns.v14.2383","article-title":"Nalirifox in the treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC): a comprehensive review","volume":"14","author":"J Paul","year":"2025","journal-title":"J. Neonatal Surg."},{"key":"10.1016\/j.biopha.2025.118786_bib57","first-page":"3","article-title":"Gemcitabine: metabolism, mechanisms of action, and self-potentiation","volume":"22","author":"Plunkett","year":"1995","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.biopha.2025.118786_bib58","article-title":"Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer","volume":"8","author":"Zhang","year":"2013","journal-title":"PLOS One"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:44:40Z","timestamp":1777013080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225009801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":58,"alternative-id":["S0753332225009801"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118786","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apoptosis-promoting autophagy mediates anti-migratory effects of unsymmetrical bisacridines in pancreatic cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118786"}}